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To investigate whether pigmentation genes involved in the melanogenic pathway (melano-
genesis) contributed to melanoma predisposition, we compared pigmentary genetics with
quantitative skin pigmentation measurements, the number of atypical nevi, the total nevus
count, and the familial atypical multiple mole and melanoma (FAMMM) syndrome. We
typed 32 pigmentary SNP markers and sequencedMC1R in 246 healthy individuals and
116 individuals attending periodic control for malignant melanoma development, 50 of
which were diagnosed with FAMMM. It was observed that individuals with any two grouped
MC1R variants (missense, NM_002386:c. 456C > A (p.TYR152*), or NM_002386:
c.83_84insA (p.Asn29Glnfs*14) had significantly (p<0.001) lighter skin pigmentation of the
upper-inner arm than those with none or oneMC1R variant. We did not observe any signifi-
cant association of theMC1R variants with constitutive pigmentation measured on the but-
tock area. We hypothesize that the effect ofMC1R variants on arm pigmentation is primarily
reflecting the inability to tan when subjected to UVR. A gender specific effect on skin pig-
mentation was also observed, and it was found that the skin pigmentation of females on
average were darker than that of males (p<0.01). We conclude thatMC1R variants are
associated with quantitative skin colour in a lightly pigmented Danish population. We did not
observe any association between any pigmentary marker and the FAMMM syndrome. We
suggest that the genetics of FAMMM is not related to the genetics of the pigmentary
pathway.
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Introduction
Human skin colour is greatly influenced by environmental factors, including ultraviolet radia-
tion (UVR). UVR is high in equatorial regions of the world, where darker skinned populations
are found, and lower in regions distant to equator, where lighter skinned populations are found
[1]. Excessive UVR of the skin induces DNA damage and is considered one of the main risk
factors of developing various skin cancers. Dark skin, with high levels of the pigment eumela-
nin, protects against UVR, because eumelanin block the effects of UVR. On the other hand,
vitamin D synthesis requires UVR and human skin colour diversity reflects the balance of let-
ting enough UVR through the skin to produce vitamin D and preventing DNA-damage caused
by UVR [2].
Melanin is produced in melanosomes, which are lysosome-related organelles present in
melanocytes. Two types of melanin are produced, pheomelanin (yellow/red) and eumelanin
(brown/black). Pheomelanin levels are rather constant among people with different skin col-
ours whereas eumelanin levels vary [3]. Eumelanin is more efficient than pheomelanin in
blocking UVR and in scavenging the reactive oxygen species produced from UVR of the skin
(reviewed in [4]). Pheomelanin confers a carcinogenic risk in mice independently of UVR [5].
Melanocytes are found in the basal layer of the skin together with keratinocytes and the two
cell types form the epidermal melanocyte unit [6]. Keratinocyte cells function as the primary
barrier against environmental damage, including UVR. DNA damage in the keratinocyte
induces expression of tumour protein p53 (P53), which induces melanin synthesis by increas-
ing the level of α-melanocyte stimulating hormone (αMSH) that binds to the melanocyte-
membrane-bound melanocortin 1 receptor (MC1R) and increases the cAMP level in the mela-
nocytes. This results in increased transcription of several pigmentation genes via microphtal-
mia associated transcription factor (MITF) (reviewed in [7]).
Many of the key genes involved in the melanogenic pathway are associated with skin colour
and skin cancer risk including agouti signalling protein (ASIP), oculocutaneous albinism 2
(OCA2), solute carrier family 45 member 2 (SLC45A2), tyrosinase (TYR), tyrosinase-related
protein 1 (TYRP1), and melanocortin 1 receptorMC1R [8–17]. Variants in theMC1R have
been studied extensively in relation to the risk of developing various skin cancers [18–21], and
certainMC1R variants are associated with increased survival of melanoma patients [22]. Muta-
tions inMC1R cause the red hair colour phenotype that is characterized by red hair, fair skin,
and inability to tan [23–27]. Mutations inMC1Rmay result in either diminished α-MSH bind-
ing or decreased cAMP signalling resulting in decreased production of eumelanin.
UVR exposure is a major health risk factor, especially in light skinned populations [28,29].
Lightly pigmented skin and a large number of atypical nevi is associated with increased risk of
developing malignant melanoma [11,30–33]. Atypical nevi are more prevalent in melanoma
patients from light than from dark skinned populations [34]. The grade of cytological atypia of
the nevi is an important risk factor for the development of malignant melanoma [35,36]. The
familial atypical multiple-mole and melanoma (FAMMM) syndrome is defined by (1) occur-
rence of melanoma in one or more first or second degree relatives, (2) large numbers of moles
(often greater than 50) some of which are atypical and often variable in size, and (3) moles that
demonstrate certain distinct histologic features [37,38]. Genetic mutations have been identified
in melanoma prone families including mutations in cyclin kinase 2A (CDKN2A) and cyclin
kinase 4 (CDK4) genes, both of which encode proteins involved in the retinoblastoma pathway
[39,40]. Genetic variants of CDKN2A are associated with the number and distribution of atypi-
cal nevi [41].
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MC1R variants can modify the penetrance of CDKN2Amutations, as carriers of mutations
in both genes are at increased risk of developing malignant melanoma compared to individuals
carrying a mutation in only one gene [31,39,42–47].
Many nevi, including common nevi, harbour the V600E mutation in the v-raf murine sar-
coma viral oncogene homolog, B1 (BRAF) [48]. V600E was observed in 60% of all melanomas
[49]. BRAF can regulate melanoma proliferation through MITF [50] that is a transcription fac-
tor and regulator of pigmentation.
Even though high melanoma risk alleles clearly exist in e.g. CDKN2A, it is speculated if the
melanoma risk might be attributable to combinations of low to moderate risk alleles in e.g.
MC1R, TYR, and ASIP [51].
In this study, we investigated the associations between SNPs in pigmentary genes and (1)
quantitative skin colour measurements in 246 healthy, light skinned Danish individuals, (2)
total nevi, (3) total atypical nevi count, and (4) the FAMMM syndrome in 116 Danish individ-
uals at increased risk of developing malignant melanoma.
Results
Associations between quantitative skin colour and genetic markers
The Pearson correlation coefficient between logarithmic transformed arm and buttock PPF
measurements was 0.51 (r2 = 0.26, data not shown). Buttock PPF measurements were statisti-
cally significantly lower than those of arm measurements for both genders in the cohort group
(p<2.3x10-16). The skin was signifcantly darker in females than in males among the cohorts at
both measurement sites (p<0.001, Figs 1A and 2B). Furthermore, female cases had statistically
significantly higher arm PPF measurements than male cases (Fig 1C). However, we did not
detect any statistically significant difference between the buttock PPF measurements of males
and females in the case group (Fig 1D). Female cases had significantly lighter skin on the
Fig 1. Comparison between skin color measurements in females andmales. Arm (A) and buttock (B) measurements in females and males of the cohort.
Arm (C) and buttock (D) measurements of female and male cases. P-values were calculated usingWelch’s two sample t-test.
doi:10.1371/journal.pone.0150381.g001
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buttock than female cohorts (p = 0.0004). However, this tendency was not observed in males
(p = 0.7), and there was no significant difference in the pigmentation levels on the arms
between cases and cohorts in either sex (p = 0.8 and p = 0.9 in females and males, respectively).
Influence of genetic variations, gender, age, and month of measurement
on PPF
Individuals from the cohort group with two or moreMC1R variants (missense, p.TYR152, or p.
Asn29Glnfs14, S2 Table) had statistically significantly lower PPF measurements of the arm (Fig
2) than those having one or noMC1R variant. We did not observe this relationship for buttock
measurements (data not shown). We performed multi linear regression model analysis of the
cohorts (n = 246) with log10(PPF) as response and gender, age, month of measurement, 22 SNPs
with sufficient observations, andMC1R variants as explanatory variables (Pane 1 S3 Table and
Pane 2 S3 Table). For arm measurements, we only observed groupedMC1R variants to deviate
statistically significantly (p<0.01). TheMC1R association was not observed when investigating a
similar multi linear regression model with buttock PPF as response. Among the tested variables,
only gender was statistically significantly associated (p<0.01) with the buttock PPF.
Associations with nevi and FAMMM
We evaluated the logistic regression model including age, gender, 22 SNPs, andMC1R for asso-
ciation with nevi count (Pane 3 S3 Table). A statistically significant association with total nevi
count prior to correction for multiple testing was observed for the G and AG genotypes of
rs6475555 on chromosome 9 (non-corrected p = 0.004 (corrected 0.18) and p = 0.005 (cor-
rected 0.24), respectively). None of the parameters were statistically significantly associated
with the total nevi count after correcting for multiple testing.
Fig 2. Comparison between skin colour measurements of the arm in male and female cohort individuals with1 or2MC1R variants. P-values
were calculated usingWelch’s two sample t-test.
doi:10.1371/journal.pone.0150381.g002
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When evaluating a logistic regression model with atypical nevi count as response (Pane 4 S3
Table), we observed statistically significant association with age (p<0.05). Healthy cohorts had a
mean age of 45.1, years and cases with atypical nevi had amean age of 38.4 years, which may explain
the statistically significant results of the model. The G and GA genotypes of rs1015362 in ASIPwere
statistically significantly associated with the atypical nevi count prior to correction for multiple test-
ing (non-corrected p = 0.008 (0.36 corrected) and p = 0.003 (0.13 corrected), respectively).
When performing the logistic regression model including FAMMM (Pane 5 S3 Table), we
observed a statistically significant association with age. This was most likely caused by the fact
that patients with FAMMM had a mean age of 36.9 years, whereas the healthy cohorts had a
mean age of 45.1 years. We did not observe any statistically significant association between the
22 SNPs orMC1R with the FAMMM syndrome, allthough that we prior to Bonferoni correc-
tion observed statistically significant associations with the vitamin D receptor (VDR) SNP
rs1544410 G and the agouti signalling protein (ASIP) SNP rs1015362 G (non-corrected
p = 0.007 (0.33 corrected) and p = 0.009 (0.43 corrected), respectively).
Discussion
The measurements of pigmentation levels demonstrated that the buttock area was statistically
significantly less pigmented than the upper-inner arm area. This implies that the buttock is a
better site for measuring constitutive pigmentation levels than the upper-inner arm, and that
the upper-inner arm measurements often reflect the tanning response of the individuals. We
observed a statistically significant difference of the logarithmic transformed PPF values
between males and females of the cohort group on both arm and buttock. This observation
supports previous observations in eye colour studies indicating that there may exist a yet
unknown biological, sex-determined mechanism controlling pigmentation levels [52,53]. On
the other hand, the darker skin pigmentation levels observed in females could also be an envi-
ronmental effect due to e.g. different sun or clothing habits (Fig 1A and 1B). The individuals in
the case group are expected to avoid extensive UV-exposure. In this group, females and males
did not have statistically significantly different PPF values of the buttock (Fig 1D), and the
effect of gender on the arm pigmentation was less pronounced (Fig 1C). This seemed to indi-
cate that the observed gender effect on pigmentation wass caused by an environmental effect.
When performing multi linear regression analysis among the cohorts, we observed that
individuals with two or moreMC1R variants had statistically significantly lower PPF values of
the arm than those with none or oneMC1R variants.MC1R variants were not statistically sig-
nificantly associated with PPF measurements on the buttock. This shows, in concordance with
established genetic theories concerningMC1R (reviewed in [54]), thatMC1R variants are
involved in human pigmentation. SinceMC1R variants are not statistically significantly associ-
ated with pigmentation measurements of the buttock, we hypothesize that the effect ofMC1R
variants on arm pigmentation is primarily reflecting an inability to tan when subjected to UVR.
Two of the genotypes of rs6475555 on chromosome 9 were, prior to correction for multiple test-
ing, statistically significantly associated with the total nevi count. This SNP was previously found
to be associated with the total nevus count in a study comprised of twins from the UK and twins
of European ancestry in Australia [55]. Falchi and colleagues hypothesized that the gene
methythoiadenosine phosphorylase (MTAP) or the adjacent CDKN2A gene are involved in the
nevus formation [55]. A SNP inMTAPwas reported to be associated with an increased number
of nevi [33] indicating the importance of theMTAP region in nevus formation.
Two of the genotypes of ASIP rs1015362 were, prior to correction for multiple testing,
found to be statistically significantly associated with the atypical nevi count. ASIP was
described as being associated with skin colour and melanoma risk [55].
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Neither the tested SNPs norMC1R was statistically significantly associated with FAMMM
after correction for multiple comparisons. This most likely reflects that FAMMM is caused by
defects in non-pigmentary systems, e.g. the retinoblastoma or P53 pathways [39,40]. It is possi-
ble that the atypical nevi observed in these individuals are by-products of signalling through
MITF rather than being caused by a specific function of the pigmentary system.
Material and Methods
Samples and DNA purification
Blood samples from 362 unrelated Danish individuals were collected. A sample of 246 healthy
individuals (cohorts) was collected at the Section of Forensic Genetics, Department of Forensic
Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, and at the Blood
Bank, Glostrup Hospital. Blood samples from 116 individuals (cases) were collected at the
Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark. The case group con-
tained individuals attending regular inspection at the Department of Dermatology at Bispeb-
jerg Hospital due to an increased risk of developing malignant melanoma. Not all case group
individuals had a definite diagnosis. All individuals in the case group were evaluated by a
trained dermatologist. Nevi count (> 50 or<50) and atypical nevi count (> 5 or< 5) were
evaluated by the Dermatologist. Atypical nevi are large nevi (>5mm in diameter) with irregular
borders and colour variations. Cases were heterogeneous and presented multiple indications;
71 cases had more than 5 atypical nevi and 59 cases had more than 50 nevi. Fifty cases were
diagnosed with FAMMM using the following criteria; 1) 100 or more melanocytic nevi, 2) one
or more melanocytic nevi greater than or equal to 8mm in its largest diameter, and 3) one or
more clinically atypical melanocytic nevi (clinically defined entities,>5 mm in diameter, with
irregular pigmentation and an irregular or diffuse edge), according to the description defined
in [56].
The individuals in the cohort group were asked to fill in a questionnaire and answer if they
had more than five large nevi (>5mm) on their skin. Individuals in the cohort group that
reported more than five large nevi were excluded from the study of atypical nevi and
FAMMM, as these individuals may represent undiagnosed case individuals. Individuals in the
cohort group that reported less than five large nevi were classified as belonging to the non-
FAMMM and the low nevi count category groups. This left 159 cohort individuals (87 pro-
vided no nevi information) and 116 case group individuals for analysis of nevi and FAMMM
and a total of 246 cohort individuals and 116 cases for analysis of quantitative skin colour
(Table 1).
DNA was purified from 200μL whole blood using the DNA Blood Mini Kit (Qiagen) as rec-
ommended by the manufacturer. DNA was eluted in 50μL AE Buffer (Qiagen). Blood samples
were collected between March 2010 and January 2012. Samples were grouped by the month of
collection, regardless of year, in order to analyse the possible seasonal variation in quantitative
skin reflectance measurements.
Table 1. Descriptive statistics of the participants. F: females. M: males. Sd; Standard deviation.














F Cohorts 112 41 11.5 0.83 0.091 0.70 0.11
F Case 73 38 8.4 0.82 0.081 0.65 0.08
M Cohorts 134 43 11.1 0.79 0.084 0.63 0.12
M Case 43 41 9.0 0.79 0.077 0.64 0.11
doi:10.1371/journal.pone.0150381.t001
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The study was approved by the Ethical Committee of the Capital region of Denmark, H-4-
2009-125 and M-20090237. All participants provided written informed consent. All individuals
included in the study reported Scandinavian parental origin. Individuals did not report regular
use of tanning beds.
Skin reflectance measurements
The quantitative skin reflectance measurements were performed using a UV-Optimize Scientific
555 (Chromo Light APS, Espergærde, Denmark). The instrument is a non-invasive spectropho-
tometer that calculates the reflectance of skin redness and pigmentation from the measured area
in percentage [57]. The instrument was calibrated with a white standard (ISO 2469).
The reflectance of a wavelength at 555nm measures the haemoglobin content and is scaled
as 0%-100% skin redness. Null percent skin redness corresponds to skin without blood, and
100 percent corresponds to highly vascular skin lesions. The reflectance of 660 nm indicates
the melanin content termed skin pigmentation when the skin redness is eliminated. A null per-
centage skin pigmentation measurement corresponds to the reflection of no pigmentation
(pale), and a 100 percentage skin pigmentation measurement corresponds to the reflection of
black skin [57]. The pigment protection factor (PPF) is a value for the protection against UVR
provided by skin pigmentation and the top layer of epidermis (stratum corneum). The PPF can
be used in parallel with the Fitzpatrick skin types [58]. Measurements were performed on the
upper, inner arm and on the buttock in triplicates for each participant. The medians of each
PPF triplicates were used for statistical analyses. All measured skin areas were free from nevi,
freckles, tattoos, and hair.
SNP typing
All 362 samples were typed for 32 SNPs, which were chosen based on their associations to vari-
ous skin malignancies and skin colours (S1 Table), using the iPLEX1 Gold kit (Sequenom) (S1
Table). The PCR contained 2μL DNA, 0.5μL 10x Buffer, 0.8μL 25mMMgCl2, 0.1μL 25mM
dNTP mix, 1.3μL 0.5μM primer mix (DNA Technology), 0.2μL 5U/μl HotStarTaq, and 1.1μL
H2O. The PCR was performed in a GeneAmp
1 PCR system 9700 thermal cycler (Applied Bio-
systems) with the following conditions: denaturation at 94°C for 2 min followed by 45 cycles of
94°C for 20 s, 62°C for 30 s, 72°C for 1 min, followed by 72°C for 3 min. The PCR products
were treated with Shrimp Alkaline Phosphatase (SAP) (Sequenom) in a GeneAmp1 PCR sys-
tem 9700 thermal cycler at 37°C for 40 min and 85°C for 5 min. The SBE reaction contained
8μl SAP treated PCR products and 2μl iPLEX1mix (Sequenom). The iPLEX1mix contained
0.2μL 10x iPLEX1 buffer, 0.2μL iPLEX1-Termination mix, 0.94μL primer mix (DNA Tech-
nology), 0.04μL iPLEX1 enzyme, and 0.62μL H2O.
The SBE reaction was performed in a GeneAmp1 PCR system 9700 thermal cycler with the
following conditions: denaturation at 94°C for 30 s followed by 40 cycles of 94°C for 5 s, 52°C
for 5 s and 80°C 5 s, 52°C for 5 s and 80°C for 5 s, 52°C for 5 s and 80°C for 5 s, 52°C for 5 s and
80°C for 5 s, 52°C for 5 s, 80°C 5 s, and 72°C for 3 min.
A total of 40μL of molecular grade water and ion exchange resin (Sequenom) was added to
each sample. Samples were rotated for approximately 4 h and kept in the refrigerator for up to
4 days before spotting. The samples were spotted in duplicates using the RS1000 Nanospotter
(Sequenom) and visualized on the MassARRAY1 analyzer 4 system (Sequenom) using the
autorun settings.
Samples were analysed with Typer Analyzer 4 (Sequenom) and were autoclustered using a
signal to noise ratio of 7. Clusterplots were visually inspected, and outliers were further
investigated.
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All samples were run in duplicates. Genotypes were compared between spots and duplicate
typings as described in [53] and implemented with the statistic software R (R core team, ver-
sion 2.11.0, URL http://www.R-project.org). The SNPs rs26722, rs28777, rs1426654,
rs1800407, rs7495174, rs8059973, rs12203592, rs12913032, rs16891982 and rs36118030 all had
minor allele frequencies (MAF)<0.01 and4 observations, and were removed from the
analysis.
Sequencing ofMC1R
TheMC1R gene of all 362 individuals was sequenced. A region encompassing theMC1R exon
and the promoter region was amplified in a single PCR amplicon of 1,963bp. Prior to library
preparation, we employed a multiplexing approach using endonuclease digestion of the PCR
product as previously described [59]. Libraries were prepared for sequencing with the Tru-
Seq1 DNA Sample Preparation kit (Illumina) and paired-end sequenced (2x250 cycles) on
the Illumina Miseq platform using the Illumina MiSeq Reagent Nano kit v2 (500 cycles).
Illumina adaptors were trimmed using Flexbar [60]. The FASTQ files were aligned to the
MC1R reference sequence assembly Feb.2009 GRCh37/hg19 (UCSC Genome Browser) with
the Burrows-Wheeler Aligner (BWA) MEM algorithm [61] to generate BAM files. Variant
Table 2. Number ofMC1R variants.
Group/MC1R variants No of individuals 0 1 2 3
Cohort 246 89 108 49 0
Cases 116 36 65 13 2
doi:10.1371/journal.pone.0150381.t002
Fig 3. Distributions of arm (A) and buttock (B) measurements in the cohort. Distribution of arm (C) and buttock (D) measurements in the cases. The black
line represents a simulated normal distribution with 10,000 observations with the same mean and standard deviation as that of the underlying data.
doi:10.1371/journal.pone.0150381.g003
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calling was carried out using GATK ver. 2.6.5 [62]. Variants were accepted if they had a mini-
mum coverage of 50. Variants, where two different alleles were observed, were accepted as het-
erozygote variant calls if the frequency of the minor variant allele was>0.15. Variants were
analysed using Alamut Batch (Interactive Biosoftware, France).MC1R variants were grouped
according to potential significance. All missense, non-sense, and frameshift mutations (S2
Table) were assigned to theMC1R variant group and analysed together (Table 2). Due to a low
number of participants and a number of unclassified variants detected, the R/r system of
MC1R mutation classification [63] was disregarded.
Statistical analyses
All statistic calculations were performed using R (R core team, version 3.1.1, URL http://www.
R-project.org). The PPF data was log transformed as this gave the best approximation to the
normal distribution. All PPF data groups passed the Anderson-Darling test for normality (Fig
3). Correlations between logaritmically transformed PPF measurements of arm and buttock
areas were investigated using the Pearson correlation coefficient. Multi linear models were per-
formed using the lm command of R. Models were performed with log10(PPF) as response and
gender, age, month of measurement, 22 SNPs with sufficient observations (MAF>0.01), and
groupedMC1R variants as explanatory variables (25 variables, 53 comparisons). Logistic
regression models were performed using the glm command of R. Models were constructed for
age, gender, 22 SNPs and asMC1R to test for association with grouped nevi count or FAMMM
(24 variables, 48 comparisons). Welch’s two sample t-test was used due to differences in sample
sizes. P-values were corrected for multiple comparisons using Bonferroni correction.
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